Omega Diagnostics Group (ODX)

 

ODX Share PerformanceMore

52 week high26.62 25/05/17
52 week low14.97 11/10/16
52 week change 1.49 (9.00%)
4 week volume1,666,061 01/07/17

Media for (ODX)

Presenter: Kieron Harbinson, Group Finance Director
07/07/2015
Presenter: Kieron Harbinson, Group Finance Director
15/04/2015

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Omega Diagnostics shareholders pass all resolutions at GM

Omega Diagnostics Group has confirmed that all resolutions, in respect of the Placing, Subscription and Open Offer, were ...

Result of General Meeting

RNS Number: 3724L Omega Diagnostics Group PLC 18 July 2017 18 July 2017 Omega Diagnostics Group plc Result of General Meeting Further to Omega's announcement of 30 June 2017, the Company is pleased to announce today the passing of the Resolutions at the General Meeting held earlier today. The Placing, Subscription and Open Offer remain conditional on A...

Omega updates on Open Offer

Omega Diagnostics Group has confirmed that it has received valid applications under the recently announced Open Offer...

Result of Open Offer

RNS Number: 2762L Omega Diagnostics Group PLC 17 July 2017 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 17 July 2017 Omega Diagnostics Group plc Result of Open Offer On 30 June 2017, Omega announced details of a Placing, Subscription and Open Offer to raise gro...

Omega updates on sale and leaseback agreement

Omega Diagnostics Group said it has concluded the sale and leaseback of the building owned by its wholly owned subsidia...

Sale and leaseback of building owned by Omega GmbH

RNS Number: 3275K Omega Diagnostics Group PLC 06 July 2017 Omega Diagnostics Group PLC ("Omega" or the "Company") Sale and leaseback of the building owned by Omega GmbH Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it has concluded the sale and leaseback of the bui...

Broker Forecast - finnCap issues a broker note on Omega Diagnostics Group PLC

finnCap today reaffirms its corporate investment rating on Omega Diagnostics Group PLC (LON:ODX) and raised its pric...

Omega successfully raises £2.6m

Omega Diagnostics has announced that the Company has raised a total of 2.6m (before expenses) with new and existing inv...

Fundamental DataMore

P/E ratio25.714
EPS0.7
Dividend yield0 %

Equity Research (ODX)

hardman & co
Omega Diagnostics Group PLC
02/05/2017
Omega Diagnostics Group has an established core business providing high quality in vitro diagnostic tests within three core areas of competence – Food Intolerance, Allergy & Autoimmune,...
hardman & co
Omega Diagnostics Group PLC
29/11/2016
Omega Diagnostics Group has an established core business providing high quality in vitro diagnostic tests within three core areas of competence – Food Intolerance, Allergy & Autoimmune,...
edison investment research
Omega Diagnostics Group PLC
05/04/2016
Edison Investment Research is terminating coverage on Omega Diagnostics Group plc (ODX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts...

Latest discussion posts More

  • why haven't Finncap got a 20p target price ?

    Finncap do not appear to have changed their price on this I wonder why ?
    18-Jun-2017
    biswell2
  • New 3-year highs today

    ODX has a highly profitable and growing core business supported by a number of "blue sky" opportunities which are now at or approaching commercialisation.
    31-May-2017
    gretel
  • New web site

    ODX have a new web site - presumably a new broom to capitalise on the transformational developments going on at present: Http://www.omegadiagnostics.com/
    8-May-2017
    gretel

Users' HoldingsMore

Users who hold Omega Diagnostics Group also hold..
LLOYDS GRP.34%
ROYAL BANK SCOT21%
SAINSBURY(J)21%
CENTRICA18%
IQE18%

Codes & Symbols

ISINGB00B1VCP282
SymbolsODX, LSE:ODX, ODX.L, ODX:LN, LON:ODX, XLON:ODX